Impact of a Prognostic 40-Gene Expression Profiling Test on Clinical Management Decisions for High-Risk Cutaneous Squamous Cell Carcinoma. J of Skin [Internet]. 2020 Sep. 2 [cited 2025 Apr. 19];4(5):s64. Available from: https://skin.dermsquared.com/skin/article/view/1013